JERSEY CITY, N.J.–(BUSINESS WIRE)–Analysis of 16,000+ VA patients switching to HADLIMA from HUMIRA showed a 1.3% switchback rate and generated $132M in estimated savings.

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.